EDUCATION

Medical School

  • The Ohio State University School of Medicine , 2006 , Columbus , OH

Internship

General Surgery
  • Indiana University School of Medicine , 2007 , Indianapolis , IN

Residency

Surgery
  • Indiana University School of Medicine , 2012 , Indianapolis , IN

Fellowship

Pediatric General Surgery
  • Boston Children's Hospital , 2015 , Boston , MA

PROFESSIONAL HISTORY

Dr. Weil's clinical interests are pediatric surgical oncology, inflammatory bowel disease, pediatric general surgery, and minimally invasive surgery.

CERTIFICATIONS

  • American Board of Surgery, General Surgery
  • American Board of Surgery, Pediatric Surgery

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Madenci AL, Dieffenbach BV, Liu Q, Yoneoka D, Knell J, Gibson TM, Yasui Y, Leisenring WM, Howell RM, Diller LR, Krull KR, Armstrong GT, Oeffinger KC, Murphy AJ, Weil BR, Weldon CB. Late-onset anorectal disease and psychosocial impact in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Cancer. 2019 Jul 19. View abstract
  2. Dieffenbach BV, Madenci AL, Murphy AJ, Weldon CB, Weil BR, Lehmann LE. Therapeutic Impact and Complications Associated with Surgical Lung Biopsy after Allogeneic Hematopoietic Stem Cell Transplantation in Children. Biol Blood Marrow Transplant. 2019 Jun 28. View abstract
  3. Madenci AL, Vandewalle RJ, Dieffenbach BV, Laufer MR, Boyd TK, Voss SD, Frazier AL, Billmire DF, Rescorla FJ, Weil BR, Weldon CB. Multicenter pre-operative assessment of pediatric ovarian malignancy. J Pediatr Surg. 2019 Sep; 54(9):1921-1925. View abstract
  4. Corkum KS, Rhee DS, Wafford QE, Demeestere I, Dasgupta R, Baertschiger R, Malek MM, Aldrink JH, Heaton TE, Weil BR, Madonna MB, Lautz TB. Fertility and hormone preservation and restoration for female children and adolescents receiving gonadotoxic cancer treatments: A systematic review. J Pediatr Surg. 2019 Jan 22. View abstract
  5. Sonderman KA, Wolf LL, Madenci AL, Kwon NK, Armstrong LB, Wanis KN, Taylor K, Uribe-Leitz T, Koehlmoos TP, Ricca RL, Weil BR, Weldon CB, Haider AH, Rice-Townsend SE. Opioid Prescription Patterns for Children Following Laparoscopic Appendectomy. Ann Surg. 2018 Dec 22. View abstract
  6. Aldrink JH, Heaton TE, Dasgupta R, Lautz TB, Malek MM, Abdessalam SF, Weil BR, Rhee DS, Baertschiger R, Ehrlich PF. Update on Wilms tumor. J Pediatr Surg. 2019 Mar; 54(3):390-397. View abstract
  7. Newman EA, Abdessalam S, Aldrink JH, Austin M, Heaton TE, Bruny J, Ehrlich P, Dasgupta R, Baertschiger RM, Lautz TB, Rhee DS, Langham MR, Malek MM, Meyers RL, Nathan JD, Weil BR, Polites S, Madonna MB. Update on neuroblastoma. J Pediatr Surg. 2019 Mar; 54(3):383-389. View abstract
  8. Madenci AL, Weil BR, Liu Q, Murphy AJ, Gibson TM, Yasui Y, Leisenring WM, Howell RM, Tinkle CL, Nekhlyudov L, Diller LR, Armstrong GT, Oeffinger KC, Weldon CB. Long-Term Risk of Venous Thromboembolism in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2018 Sep 14; JCO2018784595. View abstract
  9. Madenci AL, Armstrong LB, Kwon NK, Jiang W, Wolf LL, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Weil BR. Incidence and risk factors for sepsis after childhood splenectomy. J Pediatr Surg. 2019 Jul; 54(7):1445-1448. View abstract
  10. Chow EJ, Antal Z, Constine LS, Gardner R, Wallace WH, Weil BR, Yeh JM, Fox E. New Agents, Emerging Late Effects, and the Development of Precision Survivorship. J Clin Oncol. 2018 07 20; 36(21):2231-2240. View abstract
  11. Weil BR, Madenci AL, Liu Q, Howell RM, Gibson TM, Yasui Y, Neglia JP, Leisenring WM, Smith SA, Tonorezos ES, Friedman DN, Constine LS, Tinkle CL, Diller LR, Armstrong GT, Oeffinger KC, Weldon CB. Late Infection-Related Mortality in Asplenic Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2018 06 01; 36(16):1571-1578. View abstract
  12. Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560. View abstract
  13. Taylor K, Sonderman KA, Wolf LL, Jiang W, Armstrong LB, Koehlmoos TP, Weil BR, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Hernia recurrence following inguinal hernia repair in children. J Pediatr Surg. 2018 Nov; 53(11):2214-2218. View abstract
  14. Onwubiko C, Weil BR, Bairdain S, Hall AM, Perkins JM, Thangarajah H, McSweeney ME, Smithers CJ. Primary laparoscopic gastrojejunostomy tubes as a feeding modality in the pediatric population. J Pediatr Surg. 2017 Sep; 52(9):1421-1425. View abstract
  15. Madenci AL, Li GZ, Weil BR, Zurakowski D, Kang PB, Weldon CB. The role of thymectomy in the treatment of juvenile myasthenia gravis: a systematic review. Pediatr Surg Int. 2017 Jun; 33(6):683-694. View abstract
  16. Weil BR, Al-Ibraheemi A, Vargas SO, Rangel SJ. Autoamputation of the Appendix Presenting as a Calcified Abdominal Mass Following Necrotizing Enterocolitis. Pediatr Dev Pathol. 2017 Jul-Aug; 20(4):335-339. View abstract
  17. Devji TF, Madenci AL, Carpino E, Leahy IC, Samnaliev M, Dearden JL, Weil BR, Weldon CB, Cravero J. Safety and cost-effectiveness of port removal outside of the operating room among pediatric patients. J Pediatr Surg. 2016 Nov; 51(11):1891-1895. View abstract
  18. Weil BR, Al-Ibraheemi A, Vargas SO, Rangel SJ. Autoamputation of the appendix presenting as a calcified abdominal mass following necrotizing enterocolitis. Pediatr Dev Pathol. 2016 Mar 28. View abstract
  19. Weil BR, Shamberger RC. Commentary on "Simultaneous Resection of High-risk Liver Tumors and Pulmonary Metastases in Children". Ann Surg. 2015 Jul; 262(1):e4. View abstract
  20. Brewster BD, Weil BR, Ladd AP. Prospective determination of percutaneous endoscopic gastrostomy complication rates in children: still a safe procedure. Surgery. 2012 Oct; 152(4):714-9; discussion 719-21. View abstract
  21. Weil BR, Leys CM, Rescorla FJ. The jury is still out: changes in gastroschisis management over the last decade are associated with both benefits and shortcomings. J Pediatr Surg. 2012 Jan; 47(1):119-24. View abstract
  22. Herrmann JL, Fiege JW, Abarbanell AM, Weil BR, Wang Y, Poynter JA, Manukyan MC, Brewster BD, Meldrum DR. TGF-a equalizes age disparities in stem cell-mediated cardioprotection. J Surg Res. 2012 Aug; 176(2):386-94. View abstract
  23. Luo Y, Wang Y, Poynter JA, Manukyan MC, Herrmann JL, Abarbanell AM, Weil BR, Meldrum DR. Pretreating mesenchymal stem cells with interleukin-1ß and transforming growth factor-ß synergistically increases vascular endothelial growth factor production and improves mesenchymal stem cell-mediated myocardial protection after acute ischemia. Surgery. 2012 Mar; 151(3):353-63. View abstract
  24. Hollander LL, Leys CM, Weil BR, Rescorla FJ. Predictive value of response to steroid therapy on response to splenectomy in children with immune thrombocytopenic purpura. Surgery. 2011 Oct; 150(4):643-8. View abstract
  25. Herrmann JL, Abarbanell AM, Wang Y, Weil BR, Poynter JA, Manukyan MC, Meldrum DR. Transforming growth factor-a enhances stem cell-mediated postischemic myocardial protection. Ann Thorac Surg. 2011 Nov; 92(5):1719-25. View abstract
  26. Weil BR, Herrmann JL, Abarbanell AM, Manukyan MC, Poynter JA, Meldrum DR. Intravenous infusion of mesenchymal stem cells is associated with improved myocardial function during endotoxemia. Shock. 2011 Sep; 36(3):235-41. View abstract
  27. Manukyan MC, Keck AC, Poynter JA, Wang Y, Weil BR, Abarbanell AM, Herrmann JL, Crowe BJ, Alvernaz C, Meldrum DR. Transforming growth factor-alpha does not protect myocardium during acute ischemia/reperfusion. Surgery. 2011 Aug; 150(2):339-46. View abstract
  28. Crowe B, Poynter JA, Manukyan MC, Wang Y, Brewster BD, Herrmann JL, Abarbanell AM, Weil BR, Meldrum DR. Pretreatment with intracoronary mimosine improves postischemic myocardial functional recovery. Surgery. 2011 Aug; 150(2):191-6. View abstract
  29. Poynter JA, Manukyan MC, Wang Y, Brewster BD, Herrmann JL, Weil BR, Abarbanell AM, Meldrum DR. Systemic pretreatment with dimethyloxalylglycine increases myocardial HIF-1a and VEGF production and improves functional recovery after acute ischemia/reperfusion. Surgery. 2011 Aug; 150(2):278-83. View abstract
  30. Manukyan MC, Alvernaz CH, Poynter JA, Wang Y, Brewster BD, Weil BR, Abarbanell AM, Herrmann JL, Crowe BJ, Keck AC, Meldrum DR. Interleukin-10 protects the ischemic heart from reperfusion injury via the STAT3 pathway. Surgery. 2011 Aug; 150(2):231-9. View abstract
  31. Poynter JA, Herrmann JL, Manukyan MC, Wang Y, Abarbanell AM, Weil BR, Brewster BD, Meldrum DR. Intracoronary mesenchymal stem cells promote postischemic myocardial functional recovery, decrease inflammation, and reduce apoptosis via a signal transducer and activator of transcription 3 mechanism. J Am Coll Surg. 2011 Aug; 213(2):253-60. View abstract
  32. Herrmann JL, Weil BR, Abarbanell AM, Wang Y, Poynter JA, Manukyan MC, Meldrum DR. IL-6 and TGF-a costimulate mesenchymal stem cell vascular endothelial growth factor production by ERK-, JNK-, and PI3K-mediated mechanisms. Shock. 2011 May; 35(5):512-6. View abstract
  33. Manukyan MC, Weil BR, Wang Y, Abarbanell AM, Herrmann JL, Poynter JA, Brewster BD, Meldrum DR. Female stem cells are superior to males in preserving myocardial function following endotoxemia. Am J Physiol Regul Integr Comp Physiol. 2011 Jun; 300(6):R1506-14. View abstract
  34. Wang Y, Abarbanell AM, Herrmann JL, Weil BR, Manukyan MC, Poynter JA, Meldrum DR. TLR4 inhibits mesenchymal stem cell (MSC) STAT3 activation and thereby exerts deleterious effects on MSC-mediated cardioprotection. PLoS One. 2010 Dec 03; 5(12):e14206. View abstract
  35. Poynter JA, Beckman DJ, Abarbanell AM, Herrmann JL, Manukyan MC, Weil BR, Bumb K, Meldrum DR. Surgical treatment of atrial fibrillation: the time is now. Ann Thorac Surg. 2010 Dec; 90(6):2079-86. View abstract
  36. Wang Y, Abarbanell AM, Herrmann JL, Weil BR, Poynter J, Manukyan MC, Crisostomo PR, Meldrum DR. Toll-like receptor signaling pathways and the evidence linking toll-like receptor signaling to cardiac ischemia/reperfusion injury. Shock. 2010 Dec; 34(6):548-57. View abstract
  37. Manukyan MC, Weil BR, Wang Y, Abarbanell AM, Herrmann JL, Poynter JA, Meldrum DR. The phosphoinositide-3 kinase survival signaling mechanism in sepsis. Shock. 2010 Nov; 34(5):442-9. View abstract
  38. Tan J, Weil BR, Abarbanell AM, Wang Y, Herrmann JL, Dake ML, Meldrum DR. Ablation of TNF-alpha receptors influences mesenchymal stem cell-mediated cardiac protection against ischemia. Shock. 2010 Sep; 34(3):236-42. View abstract
  39. Abarbanell AM, Hartley JA, Herrmann JL, Weil BR, Wang Y, Manukyan MC, Poynter JA, Meldrum DR. Exogenous high-mobility group box 1 improves myocardial recovery after acute global ischemia/reperfusion injury. Surgery. 2011 Mar; 149(3):329-35. View abstract
  40. Weil BR, Manukyan MC, Herrmann JL, Abarbanell AM, Poynter JA, Wang Y, Meldrum DR. The immunomodulatory properties of mesenchymal stem cells: implications for surgical disease. J Surg Res. 2011 May 01; 167(1):78-86. View abstract
  41. Weil BR, Ladd AP, Yoder K. Pericardial effusion and cardiac tamponade associated with central venous catheters in children: an uncommon but serious and treatable condition. J Pediatr Surg. 2010 Aug; 45(8):1687-92. View abstract
  42. Weil BR, Manukyan MC, Herrmann JL, Wang Y, Abarbanell AM, Poynter JA, Meldrum DR. Mesenchymal stem cells attenuate myocardial functional depression and reduce systemic and myocardial inflammation during endotoxemia. Surgery. 2010 Aug; 148(2):444-52. View abstract
  43. Weil BR, Manukyan MC, Herrmann JL, Wang Y, Abarbanell AM, Poynter JA, Meldrum DR. Signaling via GPR30 protects the myocardium from ischemia/reperfusion injury. Surgery. 2010 Aug; 148(2):436-43. View abstract
  44. Herrmann JL, Abarbanell AM, Weil BR, Manukyan MC, Poynter JA, Brewster BJ, Wang Y, Meldrum DR. Optimizing stem cell function for the treatment of ischemic heart disease. J Surg Res. 2011 Mar; 166(1):138-45. View abstract
  45. Kelly ML, Wang M, Crisostomo PR, Abarbanell AM, Herrmann JL, Weil BR, Meldrum DR. TNF receptor 2, not TNF receptor 1, enhances mesenchymal stem cell-mediated cardiac protection following acute ischemia. Shock. 2010 Jun; 33(6):602-7. View abstract
  46. Herrmann JL, Abarbanell AM, Weil BR, Wang Y, Poynter JA, Manukyan MC, Meldrum DR. Postinfarct intramyocardial injection of mesenchymal stem cells pretreated with TGF-alpha improves acute myocardial function. Am J Physiol Regul Integr Comp Physiol. 2010 Jul; 299(1):R371-8. View abstract
  47. Weil BR, Andreoli SP, Billmire DF. Bleeding risk for surgical dialysis procedures in children with hemolytic uremic syndrome. Pediatr Nephrol. 2010 Sep; 25(9):1693-8. View abstract
  48. Herrmann JL, Abarbanell AM, Weil BR, Manukyan MC, Poynter JA, Wang Y, Coffey AC, Meldrum DR. Gender dimorphisms in progenitor and stem cell function in cardiovascular disease. J Cardiovasc Transl Res. 2010 Apr; 3(2):103-13. View abstract
  49. Abarbanell AM, Wang Y, Herrmann JL, Weil BR, Poynter JA, Manukyan MC, Meldrum DR. Toll-like receptor 2 mediates mesenchymal stem cell-associated myocardial recovery and VEGF production following acute ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2010 May; 298(5):H1529-36. View abstract
  50. Herrmann JL, Wang Y, Abarbanell AM, Weil BR, Tan J, Meldrum DR. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection. Shock. 2010 Jan; 33(1):24-30. View abstract
  51. Herrmann JL, Abarbanell AM, Weil BR, Wang Y, Wang M, Tan J, Meldrum DR. Cell-based therapy for ischemic heart disease: a clinical update. Ann Thorac Surg. 2009 Nov; 88(5):1714-22. View abstract
  52. Weil BR, Meldrum DR. What's new in Shock, October 2009? Shock. 2009 Oct; 32(4):345-7. View abstract
  53. Abarbanell AM, Coffey AC, Fehrenbacher JW, Beckman DJ, Herrmann JL, Weil B, Meldrum DR. Proinflammatory cytokine effects on mesenchymal stem cell therapy for the ischemic heart. Ann Thorac Surg. 2009 Sep; 88(3):1036-43. View abstract
  54. Wang Y, Weil BR, Herrmann JL, Abarbanell AM, Tan J, Markel TA, Kelly ML, Meldrum DR. MEK, p38, and PI-3K mediate cross talk between EGFR and TNFR in enhancing hepatocyte growth factor production from human mesenchymal stem cells. Am J Physiol Cell Physiol. 2009 Nov; 297(5):C1284-93. View abstract
  55. Herrmann JL, Markel TA, Abarbanell AM, Weil BR, Wang M, Wang Y, Tan J, Meldrum DR. Proinflammatory stem cell signaling in cardiac ischemia. Antioxid Redox Signal. 2009 Aug; 11(8):1883-96. View abstract
  56. Weil BR, Markel TA, Herrmann JL, Abarbanell AM, Meldrum DR. Mesenchymal stem cells enhance the viability and proliferation of human fetal intestinal epithelial cells following hypoxic injury via paracrine mechanisms. Surgery. 2009 Aug; 146(2):190-7. View abstract
  57. Vornehm ND, Wang M, Abarbanell A, Herrmann J, Weil B, Tan J, Wang Y, Kelly M, Meldrum DR. Acute postischemic treatment with estrogen receptor-alpha agonist or estrogen receptor-beta agonist improves myocardial recovery. Surgery. 2009 Aug; 146(2):145-54. View abstract
  58. Abarbanell AM, Herrmann JL, Weil BR, Wang Y, Tan J, Moberly SP, Fiege JW, Meldrum DR. Animal models of myocardial and vascular injury. J Surg Res. 2010 Aug; 162(2):239-49. View abstract
  59. Weil BR, Markel TA, Herrmann JL, Abarbanell AM, Kelly ML, Meldrum DR. Stem cells in sepsis. Ann Surg. 2009 Jul; 250(1):19-27. View abstract
  60. Wang M, Tan J, Coffey A, Fehrenbacher J, Weil BR, Meldrum DR. Signal transducer and activator of transcription 3-stimulated hypoxia inducible factor-1alpha mediates estrogen receptor-alpha-induced mesenchymal stem cell vascular endothelial growth factor production. J Thorac Cardiovasc Surg. 2009 Jul; 138(1):163-71, 171.e1. View abstract
  61. Wang M, Wang Y, Abarbanell A, Tan J, Weil B, Herrmann J, Meldrum DR. Both endogenous and exogenous testosterone decrease myocardial STAT3 activation and SOCS3 expression after acute ischemia and reperfusion. Surgery. 2009 Aug; 146(2):138-44. View abstract
  62. Wang Y, Wang M, Abarbanell AM, Weil BR, Herrmann JL, Tan J, Novotny NM, Coffey AC, Meldrum DR. MEK mediates the novel cross talk between TNFR2 and TGF-EGFR in enhancing vascular endothelial growth factor (VEGF) secretion from human mesenchymal stem cells. Surgery. 2009 Aug; 146(2):198-205. View abstract
  63. Weil BR, Abarbanell AM, Herrmann JL, Wang Y, Meldrum DR. High glucose concentration in cell culture medium does not acutely affect human mesenchymal stem cell growth factor production or proliferation. Am J Physiol Regul Integr Comp Physiol. 2009 Jun; 296(6):R1735-43. View abstract
  64. Zeller CN, Wang Y, Markel TA, Weil B, Abarbanell A, Herrmann JL, Kelly ML, Coffey A, Meldrum DR. Role of tumor necrosis factor receptor 1 in sex differences of stem cell mediated cardioprotection. Ann Thorac Surg. 2009 Mar; 87(3):812-9. View abstract
  65. Wang M, Wang Y, Weil B, Abarbanell A, Herrmann J, Tan J, Kelly M, Meldrum DR. Estrogen receptor beta mediates increased activation of PI3K/Akt signaling and improved myocardial function in female hearts following acute ischemia. Am J Physiol Regul Integr Comp Physiol. 2009 Apr; 296(4):R972-8. View abstract
  66. Lahm T, Crisostomo PR, Markel TA, Wang M, Wang Y, Weil B, Meldrum DR. Exogenous estrogen rapidly attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction. Shock. 2008 Dec; 30(6):660-7. View abstract
  67. Wang Y, Crisostomo PR, Wang M, Weil B, Abarbanell A, Poynter J, Manukyan MC, Meldrum DR. Nitric oxide suppresses the secretion of vascular endothelial growth factor and hepatocyte growth factor from human mesenchymal stem cells. Shock. 2008 Nov; 30(5):527-31. View abstract
  68. Sharma R, Markel TA, Wang Y, Crisostomo PR, Wang M, Sando IC, Weil BR, Meldrum DR. Proestrus female rats are more resistant to right ventricular pressure overload. Shock. 2008 Sep; 30(3):318-23. View abstract
  69. Weil BR, Howard TJ, Zyromski NJ. Spontaneous duodenal hematoma: a rare cause of upper gastrointestinal tract obstruction. Arch Surg. 2008 Aug; 143(8):794-6. View abstract
  70. Lahm T, Crisostomo PR, Markel TA, Wang M, Weil BR, Novotny NM, Meldrum DR. The effects of estrogen on pulmonary artery vasoreactivity and hypoxic pulmonary vasoconstriction: potential new clinical implications for an old hormone. Crit Care Med. 2008 Jul; 36(7):2174-83. View abstract
  71. Ray R, Herring CM, Markel TA, Crisostomo PR, Wang M, Weil B, Lahm T, Meldrum DR. Deleterious effects of endogenous and exogenous testosterone on mesenchymal stem cell VEGF production. Am J Physiol Regul Integr Comp Physiol. 2008 May; 294(5):R1498-503. View abstract
  72. Palomera S, Baron C, Weil B, Lang P. Comparison between allogeneic and xenogeneic lymphocyte reactivity. Transplant Proc. 1996 Oct; 28(5):2915-6. View abstract
  73. Baron C, Lang P, Bierre V, Rostoker G, Weil B. Split tolerance in chimeric GVH mice. Transpl Int. 1994; 7 Suppl 1:S606-10. View abstract
  74. Laurent J, Philippon C, Lagrue G, Laurent G, Weil B, Rostoker G. Proteinuria selectivity index--prognostic value in lipoid nephrosis and related diseases. Nephron. 1993; 65(2):185-9. View abstract